News

ERDERA - 2025 Call on pre-clinical therapy studies for rare diseases open

Published on | 1 month ago

Programmes Health

The European Partnership on Rare Diseases (ERDERA) has opened its first Joint Transnational Call for Proposals on 'Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation'. The timeline of the call is as follows:

  • Pre-proposal Submission Deadline: 13 February 2025
  • Full Proposal Invitations: Early May 2025
  • Funding Decisions: December 2025


Research Foundation Flanders (FWO) participates in this call. More information on available funding for researchers based in Flanders and on who can apply & how is specified in the call documents. Questions? Please contact europe@fwo.be .

Projects should address at least two of the following:

  • Development of novel therapies in a pre-clinical setting.
  • Creation and validation of predictive and pharmacodynamic biomarkers.
  • Replication of pre-clinical findings to enhance reliability.
  • Pre-clinical proof-of-concept studies for therapy readiness.

Please note, certain approaches, including ATMP therapies and clinical trials, are excluded from this call. Detailed eligibility criteria are outlined in the Call Guidelines.

More information is available on the ERDERA website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1523 articles available search in articles 

Testimonial

image of GLAUKOS - Circular Solution for the Textile Industry

GLAUKOS - Circular Solution for the Textile Industry

Bio Base Europe Pilot Plant coordinated the Glaukos project, which answered the call topic published in 2019 of Horizon 2020 Framework Programme ‘Develop bio-based fibres and/or functional molecules to improve the performance of textile products’ under the Framework of the Bio-based Industries Joint Undertaking (BBI JU). The consortium partners took up this challenge by valorising industrial side streams and setting up a circular approach to the textile industry.